Moderna Total Liabilities increased by 10.6% to $4.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.7%, from $2.64B to $4.08B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -5.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.45B | $10.80B | $10.52B | $10.53B | $8.06B | $8.06B | $6.74B | $5.26B | $4.94B | $6.00B | $4.57B | $3.91B | $3.97B | $3.88B | $3.24B | $2.64B | $2.61B | $2.81B | $3.69B | $4.08B |
| QoQ Change | — | +14.3% | -2.5% | +0.1% | -23.5% | +0.1% | -16.5% | -21.9% | -6.2% | +21.5% | -23.7% | -14.4% | +1.4% | -2.3% | -16.4% | -18.6% | -1.0% | +7.4% | +31.5% | +10.6% |
| YoY Change | — | — | — | — | -14.7% | -25.3% | -36.0% | -50.0% | -38.8% | -25.7% | -32.1% | -25.7% | -19.6% | -35.3% | -29.1% | -32.6% | -34.2% | -27.6% | +13.8% | +54.7% |